Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Lung Cancer. 2020 Feb 26;142:90–97. doi: 10.1016/j.lungcan.2020.02.018

Figure 5.

Figure 5.

Kaplan-Meier time to progression for: (a) radiomic risk score for patients in validation set D2, (b) radiomic risk score for patients in D3 and (c) radiomic risk score for patients in D4. A significant association of the radiomics signature with TTP was observed in the validation dataset D2, D3 and D4.

HHS Vulnerability Disclosure